Table 2.

Association of outcomes in patients with CKD with potentially preventable HACs

Potentially Preventable HACsMortality: Index Hospitalizationa (95% CI)Mortality: Discharge to 90 da (95% CI)Incremental LOS (d),b median (95% CI)Readmission Discharge to 90 da (95% CI)
≥1 4.67 (4.17 to 5.22)1.08 (0.94 to 1.25)c9.86 (9.25 to 10.47)1.24 (1.15 to 1.34)
13.56 (3.11 to 4.07)1.17(0.99 to 1.38)c7.20 (6.54 to 7.96)1.21(1.11 to 1.32)
2–36.52 (5.50 to 7.73)0.91 (0.71 to 1.18)c12.09 (11.81 to 13.98)1.28 (1.12 to 1.46)
4–510.47 (7.78 to 14.08)0.88 (0.54 to 1.44)c17.14 (14.94 to 19.34)1.35 (1.04 to 1.75)
>518.89 (12.12 to 29.44)1.29 (0.67 to 2.47)c39.92 (36.54 to 43.30)1.48 (1.00 to 219)
  • HAC, hospital-acquired complication; 95% CI, 95% confidence interval; LOS, length of stay.

  • a Fully adjusted for age, admission type (elective versus urgent), sex, LOS, severity of CKD, nonpreventable complications, and 16 comorbid conditions.

  • b Fully adjusted for age, admission type (elective versus urgent), sex, severity of CKD, nonpreventable complications, and 16 comorbid conditions. Comorbid conditions: cancer, cerebrovascular disease, congestive heart failure, chronic obstructive pulmonary disease, dementia, diabetes with complications, diabetes with no complications, HIV/AIDS, metastatic solid tumor, myocardial infarction, mild liver disease, moderate/severe liver disease, para/hemiplegia, peptic ulcer disease, peripheral vascular diseases, rheumatologic diseases; reference: admissions without HAC.

  • c Nonsignificant.